Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence

Published:2017-01-09 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Mazor Yariv,Sachsenmeier Kris F.,Yang Chunning,Hansen Anna,Filderman Jessica,Mulgrew Kathy,Wu Herren,Dall’Acqua William F.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep40098.pdf

Reference51 articles.

1. Reichert, J. M. Antibodies to watch in 2016. MAbs 8, 197–204, doi: 10.1080/19420862.2015.1125583 (2016).

2. Carter, P. J. Potent antibody therapeutics by design. Nat Rev Immunol 6, 343–357, doi: 10.1038/nri1837 (2006).

3. Nelson, A. L., Dhimolea, E. & Reichert, J. M. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 9, 767–774, doi: 10.1038/nrd3229 (2010).

4. Reichert, J. M. & Dhimolea, E. The future of antibodies as cancer drugs. Drug discovery today 17, 954–963, doi: 10.1016/j.drudis.2012.04.006 (2012).

5. Chan, A. C. & Carter, P. J. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 10, 301–316, doi: 10.1038/nri2761 (2010).

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release;mAbs;2024-08-28

2. Multiple biological characteristics and functions of intestinal biofilm extracellular polymers: friend or foe?;Frontiers in Microbiology;2024-08-19

3. Engineering synthetic agonists for targeted activation of Notch signaling;2024-08-06

4. Strengthened binding affinity of bispecific antibody nanoplatforms improved the anti-tumor efficacy;Chemical Engineering Journal;2024-08

5. Single-Domain Antibodies as Antibody–Drug Conjugates: From Promise to Practice—A Systematic Review;Cancers;2024-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3